Viewing data from:

ADASUVE

NDA

LOXAPINE | N022549 | NOVA PNEUMA INC

1 strength1 unique patent0 unique exclusivities

Patent Timeline

1 unique patent by expiration date

Expiring < 1yr (1)Today

Today

Oct. 23, 2026

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain1 active DMF1 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

MEDICHEM SALOXAPINE BASE

DMF 231442009

INSTITUTE DRUG TECHNOLOGY AUSTRALIA LTDInactiveLOXAPINE BASE

DMF 131351998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

6 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — 10MG

RLD

1 patent0 exclusivities▴

POWDER;INHALATION | Approved: Dec 21, 2012

Patent #	Expiration	PED	Drug Substance	Drug Product	Use Code	Delist
8387612	Oct 23, 2026	—	—	Yes	—	—